Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer

Published:2011-12-29 Issue:26 Volume:365 Page:2473-2483
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Burger Robert A.,Brady Mark F.,Bookman Michael A.,Fleming Gini F.,Monk Bradley J.,Huang Helen,Mannel Robert S.,Homesley Howard D.,Fowler Jeffrey,Greer Benjamin E.,Boente Matthew,Birrer Michael J.,Liang Sharon X.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1104390

Cited by 2021 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ATEC23 Challenge: Automated prediction of treatment effectiveness in ovarian cancer using histopathological images;Medical Image Analysis;2025-01

2. Real-world trends in the use of maintenance therapy in ovarian cancer across the United States from 2017 to 2021;Gynecologic Oncology;2024-11

3. Efficacy of a platinum-based chemotherapy rechallenge for platinum-sensitive recurrence after PARP inhibitor maintenance;Gynecologic Oncology Reports;2024-10

4. Vaccination with folate receptor-alpha peptides in patients with ovarian cancer following response to platinum-based therapy: A randomized, multicenter clinical trial;Gynecologic Oncology;2024-10

5. Budget impact of dostarlimab plus carboplatin-paclitaxel for primary advanced or recurrent endometrial cancer from a third-party US payer perspective;Journal of Medical Economics;2024-09-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP